文献速递母胎医学产科

接受胎儿镜激光光凝术的II型或III型选择性胎儿生长受限合并孤立性羊水过少的单绒毛膜双胎3岁时婴儿结局

Infant outcome at 3 years of age of monochorionic twins with Type-II or -III selective fetal growth restriction and isolated oligohydramnios that underwent fetoscopic laser photocoagulation.
PubMed 文献 · Ultrasound Obstet Gynecol · 2024-01-01

这项多中心前瞻性队列研究纳入45例因II型或III型选择性胎儿生长受限合并羊水过少而接受胎儿镜激光光凝术的单绒毛膜双羊膜囊双胎,评估矫正胎龄40周及3岁时双胎均无严重并发症的存活率。结果显示生长受限胎儿的无并发症存活率在40周为51.1%、3岁时为46.7%,而较大胎儿分别为95.5%和86.4%。作者认为该干预可能是可行的管理选择,且优于期待治疗。

要点

  • 生长受限胎儿3岁时无神经发育疾病存活率为46.7%(21/45),较大胎儿为86.4%(38/45)。
  • 未达无并发症存活的24例生长受限胎儿中,22例(91.7%)发生胎儿或婴儿死亡(除流产外),1例神经发育损害。
  • 未达无并发症存活的6例(13.6%)较大胎儿均存在神经系统疾病。

核心结论

  • 因选择性胎儿生长受限合并脐动脉多普勒异常及孤立性羊水过少而接受胎儿镜激光光凝术的生长受限胎儿及其较大胎儿,分别表现出低神经发育疾病率和低死亡率。
  • 因此,针对II型或III型选择性胎儿生长受限合并羊水过少,胎儿镜激光光凝术可能是可行的管理选择,且优于期待治疗。

研究设计与样本

  • 多中心前瞻性队列研究,纳入45例在16至25周妊娠间因选择性胎儿生长受限接受胎儿镜激光光凝术的单绒毛膜双羊膜囊双胎。
  • 手术指征为II型或III型选择性胎儿生长受限且生长受限胎儿羊水最大垂直暗区≤2 cm,且无典型双胎输血综合征诊断。
  • 主要结局为矫正胎龄40周及3岁时双胎均无并发症的存活率。

主要发现

  • 45例选择性胎儿生长受限中,30例(66.7%)为II型,15例(33.3%)为III型。
  • 矫正胎龄40周时,生长受限胎儿无并发症存活率为51.1%(n=23),较大胎儿为95.5%(n=42)。
  • 3岁时,生长受限胎儿无并发症存活率为46.7%(n=21),较大胎儿为86.4%(n=38)。
  • 发生1例流产。
  • 3岁时未达无并发症存活的24例生长受限胎儿中,22例(91.7%)发生胎儿或婴儿死亡(除流产外),1例发生神经发育损害。

关键数值与推荐

  • 矫正胎龄40周无并发症存活定义为存活且无III级或IV级脑室内出血或囊性脑室周围白质软化。
  • 3岁时无并发症存活定义为存活且无神经发育疾病,包括脑性瘫痪、总发育商<70的神经发育损害、双侧耳聋或双侧失明。

临床怎么用

  • 作者认为,对于II型或III型选择性胎儿生长受限合并羊水过少,胎儿镜激光光凝术可能是可行的管理选择,且优于期待治疗。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To examine infant outcomes at 3 years of age in monochorionic twin pregnancies with Type-II or -III selective fetal growth restriction (sFGR) and isolated oligohydramnios who underwent fetoscopic laser photocoagulation (FLP). METHODS: This multicenter prospective cohort study included monochorionic diamniotic twins that underwent FLP for sFGR between 16 and 25 weeks' gestation. The indication for performing FLP was Type-II or -III sFGR with oligohydramnios of the growth-restricted (FGR) twin in which the maximum vertical pocket of amniotic fluid was ≤ 2 cm. This was done in the absence of a typical diagnosis of twin-twin transfusion syndrome. The primary outcome was intact survival rate of both infants at the corrected gestational age of 40 weeks and at 3 years of age. Intact survival at the corrected age of 40 weeks was defined as survival without Grade-III or -IV intraventricular hemorrhage or cystic periventricular leukomalacia. Intact survival at 3 years of age was defined as survival without neurodevelopmental morbidity, which included cerebral palsy, neurodevelopmental impairment with a total developmental quotient of < 70, bilateral deafness or bilateral blindness. RESULTS: Among 45 patients with sFGR, 30 (66.7%) were classified as having Type-II and 15 (33.3%) as Type-III sFGR. The prevalence of intact survival at the corrected age of 40 weeks was 51.1% (n = 23) in FGR twins and 95.5% (n = 42) in larger twins. The prevalence of intact survival at 3 years of age was 46.7% (n = 21) in FGR twins and 86.4% (n = 38) in larger twins. There was one case of miscarriage. Among the 24 FGR twins who were not classified as having intact survival at 3 years of age, 22 (91.7%) cases suffered fetal or infant demise (other than miscarriage), and there was one case of neurodevelopmental impairment. All larger twins who were not diagnosed with intact survival at 3 years of age (n = 6 (13.6%)) had neurological morbidity. CONCLUSIONS: FGR twins and their larger cotwins, when subjected to FLP owing to sFGR coupled with umbilical artery Doppler abnormalities and isolated oligohydramnios, exhibit low rates of neurological morbidity and low mortality, respectively. Therefore, FLP for Type-II or -III sFGR with oligohydramnios may be a feasible management option and one that is preferable to expectant management. © 2023 International Society of Ultrasound in Obstetrics and Gynecology.

来源:Ultrasound Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Yamamoto R, Ozawa K, Wada S, et al. Infant outcome at 3 years of age of monochorionic twins with Type-II or -III selective fetal growth restriction and isolated oligohydramnios that underwent fetoscopic laser photocoagulation. Ultrasound Obstet Gynecol. 2024. PMID: 38031151. doi:10.1002/uog.27551

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。